Resmed Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Next up, we're very fortunate to be joined by Rob Douglas, the COO of ResMed. In a moment, I'll hand over to Rob and invite him to make some introductory comments. Please do, as we go through the session, please shoot me any questions that you may have via e-mail. My e-mail is [email protected]. If I don't manage to get to them through the session, I'll endeavor to follow-up with the company. This session is due to last about 40 minutes or so. We're going to try and keep it interactive. And I'll hand it over to Rob, and we'll go from there. Thanks, Rob.
Great. Thanks, Chris, and thank you, everyone, for joining. Just a few brief comments before we launch. The -- we reported our results about 4 weeks ago. And really, the story there is a sort of steady recovering new patient flow. The results were distorted versus last year as probably for many companies, given we had extremely unusual few quarters this time last year. But
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
